Sharechat Logo

Hellaby appoints Grant Samuel to assess 'opportunistic' takeover bid

Monday 3rd October 2016

Text too small?

Hellaby Holdings has appointed independent adviser Grant Samuel to prepare a report to shareholders on what the board says is an "opportunistic" takeover bid that doesn't represent fair value for the company. 

Grant Samuel will prepare an independent report for Hellaby shareholders to weigh the merits of Bapcor's $322.5 million offer, though the board's preliminary view is that it undervalues the company. Hellaby has also hired legal advisory firm Harmos Horton Lusk and Forsyth Barr's investment banking team to help the board evaluate the offer, it said in a statement. 

"The preliminary view of the independent Hellaby directors is that the offer from Bapcor is opportunistic and does not represent fair value for Hellaby," the company said. "The directors recommend that shareholders do not sell their shares or enter into any commitment to accept the proposed offer, pending further communication from Hellaby."

The Preston, Victoria-based company is offering $3.30 a share, entering into lock-up agreements with Salt Funds Management, Accident Compensation Corp and Hugh Green Holdings’ Castle Investments, securing almost 30 percent of the NZX-listed firm. 

Hellaby’s shares have climbed above the offer price, recently trading at $3.32, and Bapcor chief executive Darryl Abotomey hasn't ruled out sweetening the deal. 

The NZX-listed company's board has established a committee of independent directors, excluding Hugh Green nominee James Sclater and managing director Alan Clarke, to consider the offer. 

Clarke joined the company last November, having headed up medical services investor Abano Healthcare, where he fended off multiple takeover bids.

Since then, Clarke has been at pains to reshape the company’s portfolio to stop it being identified as a diversified investment firm, whittling its focus to being a long-term investor in the automotive and resources services sectors.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update